0001104659-23-062815.txt : 20230519
0001104659-23-062815.hdr.sgml : 20230519
20230519200818
ACCESSION NUMBER: 0001104659-23-062815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230519
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marquet Magda
CENTRAL INDEX KEY: 0001631486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40363
FILM NUMBER: 23942136
MAIL ADDRESS:
STREET 1: ALTHEADX INC.
STREET 2: 3550 DUNHILL STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcode Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829635
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811065054
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-301-6857
MAIL ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
tm2316383-5_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-05-19
0
0001829635
Transcode Therapeutics, Inc.
RNAZ
0001631486
Marquet Magda
C/O TRANSCODE THERAPEUTICS, INC.
6 LIBERTY SQUARE, #2382
BOSTON
MA
02109
1
0
0
0
0
Stock Option (right to buy)
0.2834
2023-05-19
4
A
0
45000
0.00
A
2033-05-18
Common Stock
45000
45000
D
The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time.
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
2023-05-19